Company / Interest Expense
Mereo BioPharma Group plc Interest Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$255.0K
FY2025
5-year range
$255.0K / $2.9M
FY2023-FY2025
Trend
-81.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $255,000 over the past 2 years.
Based on SEC 10-K filings.
$255,000 in FY2025.
Improved from $3M to $255,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense decreased 81.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $255.0K | -81.4% |
| FY2024 | $1.4M | -52.4% |
| FY2023 | $2.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 27, 2026